Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)

Clinical trial NCT04347967 · UNKNOWN

Trial details

NCT number: NCT04347967
Sponsor: Meridigen Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome

Start date: 2024-01-01
Primary completion: 2024-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.